Breaking news

Abu Dhabi’s PureHealth Expands Its Global Reach With Greek And Cypriot Hospital Takeover

Abu Dhabi’s state-owned PureHealth Holding PJSC is set to acquire a 60% stake in the Greek healthcare giant Hellenic Healthcare Group (HHG) in a deal valued at around $2.3 billion. This move signals a major shift in the private healthcare sector in Greece and Cyprus.

CVC Capital Partners, currently holding a 35% stake in HHG, will retain its share. At the same time, the founder of the Greek healthcare provider will maintain the remaining ownership, according to the agreement’s details.

The deal brings together HHG’s impressive portfolio, which includes some of Greece’s most renowned hospitals—Metropolitan, Hygeia, Metropolitan General, and Mitera—alongside key medical facilities in Cyprus, such as Apollonion Private Hospital, Aretaeio, and American Medical Center.

With this acquisition, PureHealth aims to drive growth by attracting more international patients and expanding its operations within Greece and Cyprus. The company has also indicated its interest in further acquisitions in the future.

PureHealth, with a market capitalization of around $11 billion, operates more than 100 hospitals and 300 clinics worldwide, employing over 56,000 staff. Recently, the company expanded its footprint by acquiring Circle Health Group, the UK’s largest private hospital network.

This acquisition aligns with PureHealth’s long-term strategy to generate half of its revenue from outside the Gulf Cooperation Council (GCC) countries. It also supports Abu Dhabi’s broader goals of diversifying its economy beyond oil and expanding its global healthcare presence.

HHG, established in 2018, currently operates 1,630 hospital beds across its network, serving over 1.3 million patients annually. With a workforce of more than 5,359 employees, the group also works with 6,662 doctors. In addition to its hospitals, HHG owns diagnostic centers such as HealthSpot and Platon Diagnosis, along with offering home healthcare services and medical equipment trading.

CVC first entered the Greek healthcare sector in 2017 by acquiring a majority stake in Metropolitan Hospital and has since expanded its portfolio with acquisitions of Iaso General Clinic and the Hygeia Group.

Dell’s Earnings Beat Puts The AI Trade To The Test

Dell Technologies has become a key stock to watch after its latest earnings report strengthened the case for continued AI infrastructure spending but failed to trigger a sustained rally.

Shares jumped more than 13% after Tuesday’s opening bell before giving back much of the gain. By late morning Wednesday, the stock was up about 5%, raising questions about whether strong AI-related earnings are still enough to drive higher valuations.

Strong Results Meet A More Skeptical Market

The reaction echoes last week’s trading in Nvidia. Its shares climbed nearly 9% after strong quarterly results and a stronger long-term outlook, only to surrender much of the advance in subsequent sessions.

That pattern has encouraged some investors to reduce exposure to AI stocks. Strong results remain evident, but markets appear less willing to reward them with sustained valuation expansion.

Dell Raises 2027 Earnings Outlook

Three months ago, Dell shares surged almost 33% after the company raised its fiscal 2027 adjusted earnings-per-share guidance by 39%. Analysts followed by lifting their own estimates, while the stock retained most of its gains.

This time, Dell raised fiscal 2027 earnings guidance to $25.50 from $17.90, an increase of about 42.5%. Street consensus rose nearly 29% overnight, yet the stock was up only about 5% in Wednesday trading.

The weaker share-price reaction suggests investors are applying a more cautious valuation to Dell than they did in May.

AI Exposure Faces Greater Caution

We have been raising cash for the Club as the AI trade has become more volatile and less predictable. Tuesday’s decision to exit Corning increased our cash position to about 15%.

If capital is redeployed, it would likely favor more defensive areas outside AI. That reflects greater caution over valuations and positioning rather than a rejection of the AI investment theme.

Dell’s Trading Could Set The Tone

A further rise in Dell shares would suggest investors remain willing to increase AI exposure, while a flat performance would point to greater valuation discipline. A decline could indicate that much of the earnings upside is already priced in.

Dell’s report, along with Broadcom’s results due Wednesday evening, could still improve sentiment across the group. If investors continue to discount strong AI earnings, however, the case for a more defensive approach will strengthen.

For now, Dell offers a real-time test of whether strong AI-related earnings can continue to drive valuations higher as investor caution increases.

Aretilaw firm
eCredo
Uol
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter